Afatinib dimaleate is the maleate salt form of afatinib, a tyrosine kinase inhibitor. It is used as a pharmaceutical raw material in the manufacturing of antineoplastic agents.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 850140-73-7
N-[4-(3-chloro-4-fluoroanilino)-7-[[(3S)-3-oxolanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide
pharmaceutical raw material
Afatinib
pharmaceutical raw material
Alogliptin
pharmaceutical raw material
Alogliptin benzoate
pharmaceutical raw material
Citalopram hydrochloride
pharmaceutical raw material
Linaclotide
pharmaceutical raw material
Afatinib, (R)-
pharmaceutical raw material
Afatinib D6
pharmaceutical raw material
bis((Z)-but-2-enedioic acid);(E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
USNRYVNRPYXCSP-JUGPPOIOSA-N
CN(C/C=C/C(=O)NC1=C(C=C2N=CN=C(C2=C1)NC3=CC(=C(C=C3)F)Cl)O[C@@H]4COCC4)C.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O